Y A SIR Q ASIM AL – MAJIDI (M R .)
B Sc. Pharm. 2013
M Sc Pharmaceutics 2018
PhD Pharmaceutics 2022
E-mail: [email protected]
Languages: Arabic & English
Creation : 18/02/2024
ACADEMIC PROFILES
• http://[email protected]
• ORCD :0000-0001-9632-0444.
• SCOPUS-profile : 82 citations, 32 documents, H-index= 5 http://www.scopus.com/inward/authorDetails.url ?authorID=57203157580&
partnerID=MN8TOARS
• R e s earchGate-profile : 126citations, 44 documents, H-index= 5 https://www.researchgate.net/profile/Yasir-Almajidi
• GoogleScholar-profile : 120 citations, 38 documents, H-index= 6 https://scholar.google.com/citations?user=soYx-QMAAAAJ&hl=ar
• WEB OF SCIENCE : 52 citations, 31 documents, H-index= 4 https://www.webofscience.com/wos/author/record/AFK-5936-2022
EDUCATION
P H D IN PHARMACEUTICS , COLLEGE OF PHARMACY, MUSTANSIRIYA UNIVERSITY, IRAQ, 2022
M S C IN PHARMACEUTICS , COLLEGE OF PHARMACY, MUSTANSIRIYA UNIVERSITY, IRAQ, 2018
BSC. IN PHARMACY, BAGHDAD COLLEGE OF PHARMACY (BAGHDAD COLLEGE OF MEDICAL SCIENCES), IRAQ, 2013
AL-KADHIMIYA SECONDARY SCHOOL, IRAQ, 2008
Lectures
Ch 1 Clinical Pharmacokinetic and Pharmacodynamic Concepts
TDM answers to problems-Lab 1
Ch 2 Clinical PK Equations and Calculations
TDM ch2
TDM Chapter 2 handouts 2020 KKA
Introduction handouts 2020_KKA
Ch 3 Drug Dosing in Special Populations
TDM Chapter 3 handouts 2020 KKA
TDM ch3
Biopharmacy Lab 1 modified 2020
lab-3-modified 2020
Video Lectures
Industrial pharmacy
Physical Pharmacy
Published Research
1/Application of nanoemulsion technology for preparation and evaluation of intranasal mucoadhesive nano-insitu gel for ondansetron HCl
2/Preparation and in vitro evaluation of montelukast sodium oral nanoemulsion
3/Preparation and Evaluation of Oroslippery Tablets Contain Irbesartan and Hydrochlorothiazide Combination for Dysphagia Patients
4/Modified solid in oil nanodispersion containing vemurafenib-lipid complex-in vitro/in vivo study
5/ Utilization of solid in oil nanodispersion to prepare a topical vemurafenib as potential delivery system for skin melanoma
6/ Preparation and In-vitro Evaluation of Lacidipine as an Oral Nanoemulsion Dosage Form
7/Preparation and In-vitro Evaluation of Lacidipine as an Oral Nanoemulsion Dosage Form
8/ Recent Trends in Chronopharmaceutics, Pulsatile Drug Delivery System
9/ An Overview on Oroslippery Technique as A Promising Alternative for Tablets used in Dysphagia
10/ ENHANCE SOLUBILITY AND PROLONG RELEASE OF PROCHLORPERAZINE MALEATE USING FLOATING NANOEMULSION IN SITU GEL
11/ Preparation and in vitro evaluation of montelukast sodium oral nanoemulsion
12/ Absolute and relative bioavailability study for the newly developed nasal nanoemulsion in situ gel of ondansetron hcl in comparison to conventionally prepared in situ gel and intravenous dosages forms
13/ Application of Nanoemulsion Technology for Preparation and Evaluation of Intranasal Mucoadhesive Nano-In-situ Gel for Ondansetron Hcl
14/Iraqi patent 2017 : 5166, 2017/411
15/ The Effect of Curcumin and Cornstarch Biopolymers on the Shelf Life of Fresh Cheese: Physicomechanical and Antimicrobial Properties
16/ Chitosan-based nanofibrous scaffolds for biomedical and pharmaceutical applications: A comprehensive review
17/ Magnetic nanocomposite based on chitosan-gelatin hydrogel embedded with copper oxide nanoparticles: A novel and promising catalyst for the synthesis of polyhydroquinoline derivatives
18/ Preparation and characterization of nanofibrous scaffolds containing copper nanoparticles and curcumin for wound healing applications
19/ A versatile magnetic nanocomposite based on cellulose-cyclodextrin hydrogel embedded with graphene oxide and Cu2O nanoparticles for catalytic application
20/ Getting to know ovarian cancer: Focusing on the effect of LncRNAs in this cancer and the effective signaling pathways
21/ A novel designed nanofibrous mat based on hydroxypropyl methyl cellulose incorporating mango peel extract for potential use in wound care system
22/ The association of exposure to polychlorinated biphenyls with lipid profile and liver enzymes in umbilical cord blood samples
23/ Utilization of Semiconductor Nanocrystals In Cancer Diagnose And Treatment
24/ Unveiling the Effect of Particle Incorporation in PEO Coatings on the Corrosion and Wear Performance of Magnesium Implants
25/ Dual-mode colorimetric and fluorescence biosensors for the detection of foodborne bacteria
26/ Keratin- and VEGF-Incorporated Honey-Based Sponge-Nanofiber Dressing: An Ideal Construct for Wound Healing
27/ A double-layer cellulose/pectin-soy protein isolate-pomegranate peel extract micro/nanofiber dressing for acceleration of wound healing
28/ Binary Ethosomal Gel for Enhanced Transdermal Delivery of Tazarotene: Development, Refinement, in vitro Evaluation, and Skin Penetration Investigations
29/ Build-in internal electric field in vacancy engineered CdS@ZnIn2S4 type-II heterostructure for boosting photocatalytic tetracycline degradation and in-situ H2O2 generation
30/ Optimization of removal of sulfonamide antibiotics by magnetic nanocomposite from water samples using central composite design
31/ Advances in chitosan-based hydrogels for pharmaceutical and biomedical applications: A comprehensive review
32/ A novel nanocomposite based on Collagen-raffinose hydrogel, embedded with carbon nitride nanosheets and ZnFe layered double hydroxides with less toxicity, antibacterial activity and enhanced mechanical properties
33/ The effect of κ-carrageenan and ursolic acid on the physicochemical properties of the electrospun nanofibrous mat for biomedical application
34/ Nanoemulsions as medicinal components in insoluble medicines
35/ Hyperbaric Oxygen in Combination with Epigallocatechin-3-Gallate Synergistically Enhance Recovery from Spinal Cord Injury in Rats
36/ Current Trends in Nanomaterials-Based Electrochemiluminescence Aptasensors for the Determination of Antibiotic Residues in Foodstuffs: A Comprehensive Review
37/ Fabrication of Fe 3 O 4 -Bis(Py-Imine)-PdCl 2 Nanocomposite as a Highly Active Nanomagnetic Catalyst for Carbonylative Suzuki Reactions of Phenylboronic Acid with Aryl Iodides and Mo(CO) 6
38/ Electrospun Polyvinylpyrrolidone/Soy protein nanofibers enriched with curcumin-loaded ZIF-8 nanoparticles: Synthesis and evaluation for wound healing application
39/ Oxidative stress affects the beginning of the growth of cancer cells through a variety of routes
40/ Chitosan-gelatin hydrogel incorporating polyvinyl alcohol and MnFe double-layered hydroxide nanocomposites with biological activity
41/ Correction: Immobilized Ni on TMEDA@βSiO 2 @αSiO 2 @Fe 3 O 4 : as a novel magnetic nanocatalyst for preparation of pyrido[2,3- d :6,5- d ′]dipyrimidines
42/ miR-495-3p as a promising tumor suppressor in human cancers
43/ Dosimetric properties of PASSAG polymer gel dosimeter in electron beam radiotherapy using magnetic resonance imaging
44/ An Environmental-friendly Procedure Based on Deep Eutectic Solvent for Extraction and Determination of Toxic Elements in Fish Species from Different Regions of Iraq
45 / Supporting wound healing by mesenchymal stem cells (MSCs) therapy in combination with scaffold, hydrogel, and matrix; State of the art
46/ Multifunctional immunosensors based on mesoporous silica nanomaterials as efficient sensing platforms in biomedical and food safety analysis: A review of current status and emerging applications
47/Nanocomposite of reduced nanographene oxide with β-lactoglobulin protein (rNGO/β-Lg) as a carrier of the anticancer drug oxaliplatin (Eloxatin)
48/ Doxorubicin-loaded micelles in tumor cell-specific chemotherapy
49/ Recent applications of microfluidic immunosensors
50/ Doxorubicin-loaded micelles in tumor cell specific chemotherapy
51/ The emerging crosstalk between atherosclerosis-related microRNAs and Bermuda triangle of foam cells: Cholesterol influx, trafficking, and efflux
52/ Nanocomposite of Reduced Nanographene Oxide with Β-Lactoglobulin Protein (Rngo/Β-Lg) as a Carrier of the Anticancer Drug Oxaliplatin (Eloxatin)
53/ Levofloxacin Adsorption onto MWCNTs/CoFe 2 O 4 Nanocomposites: Mechanism, and Modeling Using Non-Linear Kinetics and Isotherm Equations
:EMPLOYMENT HISTORY
Dec 2022 – Jan 2024 ::::Officially holds the university degree of PhD of Pharmacy College-Mustansiriya University with Excellent degree (91.5), Dean assistant and chief of pharmaceutics department at Baghdad College of Medical Sciences, Baghdad, Iraq
Jun 2021 ::: Officially holds promotion degree of lecturer (5/5/2021) from Babylon university.
Dec 2018 – 2022 :::: Officially holds the university degree of Master of Pharmacy College-Mustansiriya University with very good degree (average 87.33) and, Assistant lecturer at Baghdad College of Medical Sciences, Baghdad, Iraq
Oct.2013 – present ::::Technician staff of Baghdad College of Medical Sciences, Baghdad, Iraq
Oct 2008 – Dec 2013 ::Scholarship student at Bagdad College of Medical Sciences (sequence; first on the undergraduate with average 77.73)
:CLINICAL EXPERIENCE
1 Technician and assistant lecturer in pharmaceutics department (physical pharmacy lab, pharmaceutical calculations, Biopharmaceutics, TDM) for 7 years.
2 Assistant lecturer responsible for the TDM, Biopharmaceutics, pharmaceutical calculations and Physical pharmacy for 3 years.
3 I have certificate of training skills from EIPICO factory 10th of Ramadan
City-EYGEPT (through Pharmacists Syndicate from 16-28/7/2012).
4 I have a patent (No 5166) from the Central Agency for Quality Control and Control, Ministry of Planning /Industrial Property in 5/12/2017.
5 I have at least 44 published research and reviews in local and global journals most of them indexed in Scopus and Clarivate.
6 I work as medical representative in different companies for two years in 2013-2015, then supervisor for one year 2015-2016, also product manager for one year in 2018 on different types of medical compliance and drugs, I am currently representing four
international companies’ tender. And this equipped me with enormous administrational and managerial skills.
7 Management many medical conferences and designed at least 30 brushers, boosters and roll-up of different drugs.
8 I have QC and QA training course certificate from DAR ALDAWA company from
15/1/2020 to 13/7/2020.
9 I have a development course in collaboration with the British Academy of Human Resources (HRDA) in Egypt / Sharm El Sheikh on 30-7-2018, which prevents the international certificate issued by HDRA.
10 Reviewing of at least 25 published articles and reviews.